Sign in

You're signed outSign in or to get full access.

Duncan Gilmour

Chief Financial Officer, Treasurer and Secretary at INTESTINTEST
Executive

About Duncan Gilmour

Duncan Gilmour (age 53) is Chief Financial Officer, Treasurer and Secretary of inTEST Corporation (INTT), appointed effective June 2021; he previously served as Americas Region Controller at ABB’s Process Automation Measurement & Analytics Division and held senior finance roles at Tyco, with earlier audit experience at PwC. He holds a BAcc Joint Honours in Economics and Accounting from the University of Glasgow and is a Chartered Accountant (ICAS) . During his tenure, INTT emphasizes a multi-year strategy that “more than doubled revenue” since early 2021, while total shareholder return fluctuated: stock closed at $12.72 (12/31/21), $10.30 (12/30/22), $13.60 (12/29/23), and $8.59 (12/31/24) .

Past Roles

OrganizationRoleYearsStrategic Impact
ABB, Inc. (Process Automation Measurement & Analytics)Americas Region Controller2017–2021Senior finance leadership in industrial tech; controllership for regional P&L
Tyco International (Corporate)Finance Director, Enterprise Support2014–2017Directed enterprise finance support functions
Tyco International (Fire Protection Products)Finance Director, Special Hazards; Americas Finance Director; Global FP&A Director; Global Controller; Director of Compliance2004–2014Led divisional finance, FP&A, controllership, and compliance across multiple global roles
Coopers & Lybrand / PwCAudit Manager; Senior Associate; Supervisor/Audit Associate1993–2004Public accounting and audit management across industries

External Roles

No external directorships or outside public company board roles disclosed for Mr. Gilmour .

Fixed Compensation

Component20232024
Annual base salary ($)271,400 282,500 (effective Apr 1, 2024)
Target bonus (% of base)Not disclosed65% (raised by 10 pts in 2024)
Actual annual bonus ($)128,843 45,906 (25% of target)

Performance Compensation

2024 Short-Term Incentive (STI)

MetricWeightThresholds/MaxActual ResultPayout Impact
Company revenue & Adjusted EBITDA matrix60%Thresholds: 80% (revenue) / 86% (Adj. EBITDA); Max: 120% (revenue) / 114% (Adj. EBITDA) Not achieved 0% of weighted component
Average Net Working Capital (vs budget)20%Max 150% of target; min performance threshold 120% of NWC target (inverse measure) Exceeded125% of weighted component
Alfamation S.p.A. revenue & EBITDA (strategic)20%Max 110% of target; min threshold 100% Not achieved 0% of weighted component
Total STI payout (as % of target)25% (paid $45,906)

The STI financial payout grid provides scaling from 0% to 175% of target based on revenue/Adj. EBITDA achievement .

2024 Long-Term Incentives (LTI) – Granted March 6, 2024

Award TypeShares/OptionsGrant-date TermsVesting
Time-vested RSAs7,356FV recognized as “Stock Awards” ($166,676 for 2024 annual awards aggregate; pro-rata expense reported) 25% per year starting Mar 6, 2025
Performance-vested RSAs (PSAs)7,355Measured on 2026 performance; proxy references Adjusted EBITDA percentage and also audited revenue vs target; vesting factor 0–150% Cliff vesting at 3 years (target date Mar 6, 2027) subject to metric
Stock options12,724Exercise price $11.33; FV expensed as “Options” ($83,383 aggregate for 2024 awards) 25% per year starting Mar 6, 2025; expiration 3/5/2034

Equity mix reflects Committee design using RSAs (retention), PSAs (pay-for-performance), and options (long-term value creation) .

Equity Ownership & Alignment

Beneficial Ownership (as of April 21, 2025)

HolderShares Beneficially Owned% of ClassComposition Notes
Duncan Gilmour86,247<1%Includes 20,825 Restricted Shares; 22,792 Performance-Based Shares; 24,943 Option Shares; and 200 shares owned by spouse

Outstanding Equity (as of Dec 31, 2024; closing price $8.59)

InstrumentStatusQuantityExercise PriceExpirationUnvested SharesMarket Value of Unvested ($)
OptionsExercisable6,07816.806/13/2031
OptionsUnexercisable2,02616.806/13/2031
OptionsExercisable6,4249.763/8/2032
OptionsUnexercisable6,4249.763/8/2032
OptionsExercisable2,01116.063/7/2033
OptionsUnexercisable6,03316.063/7/2033
OptionsUnexercisable12,72411.333/5/2034
RSAs/PSAsUnvested497$4,269
RSAs/PSAsUnvested10,247$88,022
RSAs/PSAsUnvested8,174$70,215
RSAs/PSAsUnvested14,711$126,367
  • Aggregate unvested RSAs/PSAs total 33,629 shares (market value $288,873 at $8.59) .
  • All outstanding option strikes ($9.76–$16.80) were above the $8.59 year-end price, implying options were out-of-the-money as of 12/31/24, limiting near-term exercise-driven selling pressure .

Ownership Policies and Alignment

  • Management ownership guidelines: CFO must hold 2x base salary in INTT stock; retain 50% of net shares until target met; as of Apr 1, 2025, CFO not yet at target due largely to share price decline, but within five-year phase-in .
  • Hedging and pledging prohibited for officers and directors under insider trading policy (no margin purchases or pledging) .
  • No related party transactions disclosed for executives/directors in the period .
  • Section 16(a) compliance: all executive officers compliant during the prior fiscal year; one late Form 4 was for a former officer, not CFO .

Employment Terms

TermDisclosure
Employment agreementAt-will; offer letter dated June 10, 2021
Initial base salary$240,000 at hire (2021)
Additional sign-on/performance equityOne-time performance-based restricted stock with target value $100,000 (vested Aug 24, 2023 at 150%)
Restrictive covenantsConfidentiality, non-competition, non-solicitation; assignment of inventions; non-disparagement
Change-of-control (CoC) protectionDouble-trigger: if terminated without Cause or resigns for Good Reason within 2 years post-CoC, receives 1 year of base salary continuation, continued benefits for 1 year, and variable performance-based compensation for that year; subject to release and 280G limitation
Equity accelerationUpon CoC, death or Disability, all equity awards become 100% vested
Severance (non-CoC)Not disclosed (no general severance terms in proxy)
ClawbackDodd-Frank compliant policy; in 2024, Company recovered erroneously awarded pay from a covered executive (not CFO) due to restatement
Trading windowsOpen-window trading only; event-specific blackouts possible

Compensation Structure Analysis

  • Increased at-risk pay in 2024: CFO’s target bonus raised to 65% of base (from prior year by +10 pts), aligning upside to financial, balance sheet, and strategic execution; actual payout was curtailed to 25% due to underperformance on financial and strategic components with partial offset from NWC discipline .
  • LTI mix blends RSAs (retention), PSAs (2026 performance), and options (long-term value creation); PSAs reference 2026 metrics, with the proxy describing Adjusted EBITDA % and also audited revenue vs target (vest factor 0–150%), indicating a 3-year performance horizon .
  • Equity award timing policy avoids opportunistic grant timing; annual grants occur on the second business day after the 10-K filing; no grants within the specified blackout window near Exchange Act reports in 2024 .
  • Use of independent consultant (Radford/Aon) with no conflicts; compensation benchmarked to market medians for similarly sized tech/industrial peers via survey data .

Risk Indicators & Red Flags

  • Options under water as of 12/31/24 reduce immediate monetization but could diminish motivational value if prolonged .
  • Ownership guideline shortfall as of Apr 1, 2025 increases alignment pressure; however, retention requirement (50% of net shares) and phase-in reduce near-term selling .
  • Company restatement triggered a clawback for a different executive; presence and enforcement of clawback policy is positive, but restatement itself is a cautionary governance data point .
  • Hedging/pledging prohibited; no pledging disclosed for CFO .

Performance Compensation (Metric Detail)

MetricWeightTarget DefinitionThreshold/Max2024 Actual vs TargetPayout
Company revenue & Adj. EBITDA matrix60%Annual budgeted revenue and Adj. EBITDAThreshold 80%/86%; Max 120%/114% Below threshold 0%
Average Net Working Capital20%Final average NWC vs budgetMin 120% (inverse); Max 150% of target Exceeded budget125%
Alfamation revenue & EBITDA20%Year 1 prorated revenue/EBITDA targetsMin 100%; Max 110% Below threshold 0%

Director/Committee and Governance Context (for compensation oversight)

  • Compensation Committee (all independent): Jeffrey A. Beck (Chair), Steven J. Abrams, Gerald J. Maginnis; 4 meetings in 2024 .
  • Say-on-pay on 2024 NEO compensation on ballot with Board “FOR” recommendation (annual frequency also on ballot with “ONE YEAR” recommended) .

Investment Implications

  • Alignment: CFO pay structure ties significant upside to revenue/Adj. EBITDA, working capital efficiency, and strategic integration (Alfamation), with 3-year PSAs targeting 2026 performance; 2024 payout at 25% underlines downside sensitivity when targets are missed .
  • Selling pressure: Near-term selling risk appears modest—options were out-of-the-money at 12/31/24 and ownership guidelines require 50% net-share retention until the 2x-salary target is met; multiple RSA tranches vest annually, but retention and policy constraints dampen immediate liquidity events .
  • Retention/CoC: Double-trigger CoC with 1x salary, benefits, and one-year variable comp plus equity acceleration provides standard-market protection without tax gross-ups; non-compete and non-solicit support continuity .
  • Execution risk: The Company states revenue more than doubled since early 2021, but 2024 TSR was down ~37% Y/Y; PSAs focused on 2026 performance raise stakes for multi-year execution, particularly on profitability and/or growth (as described) .

No related-party transactions disclosed; Section 16 compliance observed; hedging/pledging prohibited—overall governance posture supports shareholder alignment .